Zobrazeno 1 - 10
of 47
pro vyhledávání: '"Gilligan AM"'
Publikováno v:
ClinicoEconomics and Outcomes Research, Vol Volume 9, Pp 485-494 (2017)
Elizabeth S Mearns,1 Michael Liang,1 Brendan L Limone,1 Adrienne M Gilligan,1 Jeffrey D Miller,1 Kathleen D Schaum,2 Curtis R Waycaster2 1Truven Health Analytics, an IBM Company, Cambridge, MA, USA; 2Smith & Nephew, Inc., Fort Worth, TX, USA Objectiv
Externí odkaz:
https://doaj.org/article/21cd03c6a6c94fc697eef2bebc54bdcf
Publikováno v:
ClinicoEconomics and Outcomes Research, Vol 2016, Iss Issue 1, Pp 153-161 (2016)
Marco Romanelli,1 Adrienne M Gilligan,2,3 Curtis R Waycaster,3,4 Valentina Dini1 1Department of Dermatology, University of Pisa, Pisa, Italy; 2Department of Life Sciences, Truven Health Analytics, Fort Worth, TX, USA; 3Department of Pharmacotherapy,
Externí odkaz:
https://doaj.org/article/67cfee52be10486194db29ef78e8cdcd
Publikováno v:
Chronic Wound Care Management and Research, Vol 2014, Iss Issue 1, Pp 49-56 (2014)
Curtis R Waycaster,1,2 Adrienne M Gilligan,1,2 Catherine T Milne3 1Smith and Nephew Inc., Fort Worth, TX, USA; 2Department of Pharmacotherapy, University of North Texas Health Sciences Center, Fort Worth, TX, USA; 3Connecticut Clinical Nursing Associ
Externí odkaz:
https://doaj.org/article/ab0266d6a4a24c2fbe4f213d306688d9
Publikováno v:
Research in Social & Administrative Pharmacy; Nov2012, Vol. 8 Issue 6, p523-532, 10p
Autor:
Raez LE; Memorial Cancer Institute/Florida Atlantic University (FAU), Thoracic Oncology, Boca Raton, Florida, USA., Kang H; Department of Medicine, University of California, San Francisco, San Francisco, USA., Ohe Y; National Cancer Center Hospital, Department of Thoracic Oncology, Tokyo, Japan., Khanal M; Real World and Access Analytics, Statistics, Eli Lilly and Company, Indianapolis, USA., Han Y; Real World and Access Analytics, Statistics, Eli Lilly and Company, Indianapolis, USA., Szymczak S; Clinical Research, Oncology, Eli Lilly and Company Poland, Lilly Corporate Center, Indianapolis, USA., Barker SS; Medical Affairs, Eli Lilly and Company, Indianapolis, USA., Gilligan AM; Value Evidence Outcomes Research and Oncology, Eli Lilly and Company, Indianapolis, USA. Electronic address: gilligan_adrienne@lilly.com.
Publikováno v:
ESMO open [ESMO Open] 2024 May; Vol. 9 (5), pp. 103444. Date of Electronic Publication: 2024 May 14.
Autor:
Bhandari NR; Eli Lilly and Company, Indianapolis, IN, USA., Gilligan AM; Eli Lilly and Company, Indianapolis, IN, USA., Myers J; Medical Decision Modeling Inc, Indianapolis, IN, USA., Ale-Ali A; Eli Lilly and Company, Indianapolis, IN, USA., Smolen L; Medical Decision Modeling Inc, Indianapolis, IN, USA.
Publikováno v:
Journal of medical economics [J Med Econ] 2024 Jan-Dec; Vol. 27 (1), pp. 348-358. Date of Electronic Publication: 2024 Mar 06.
Autor:
De Braud F; Department of Oncology and Hematology-Oncology, University of Milan, 20133 Milan, Italy., Deschler-Baier B; Department of Internal Medicine, University Hospital Würzburg, 97080 Würzburg, Germany., Morris JC 3rd; Department of Endocrinology, The Mayo Clinic, Rochester, MN 55905, USA., Worden F; Department of Internal Medicine, University of Michigan, Ann Arbor, MI 48105, USA., Han Y; Value Evidence Outcomes, Eli Lilly and Company, Indianapolis, IN 46285, USA., Kiiskinen U; Value Evidence Outcomes, Eli Lilly and Company, Indianapolis, IN 46285, USA., Jen MH; Value Evidence Outcomes, Eli Lilly and Company, Indianapolis, IN 46285, USA., Barker SS; Value Evidence Outcomes, Eli Lilly and Company, Indianapolis, IN 46285, USA., Szymczak S; Value Evidence Outcomes, Eli Lilly and Company, Indianapolis, IN 46285, USA., Gilligan AM; Value Evidence Outcomes, Eli Lilly and Company, Indianapolis, IN 46285, USA.
Publikováno v:
Cancers [Cancers (Basel)] 2023 Dec 27; Vol. 16 (1). Date of Electronic Publication: 2023 Dec 27.
Autor:
Dolph M; Purple Squirrel Economics, New York, NY, USA., Tremblay G; Purple Squirrel Economics, New York, NY, USA., Gilligan AM; Karyopharm Therapeutics, Newton, MA, USA., Leong H; Karyopharm Therapeutics, Newton, MA, USA.
Publikováno v:
Journal of health economics and outcomes research [J Health Econ Outcomes Res] 2021 Aug 25; Vol. 8 (2), pp. 26-35. Date of Electronic Publication: 2021 Aug 25 (Print Publication: 2021).
Autor:
Gounder M; Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, NY 10021, USA., Abdul Razak AR; Toronto Sarcoma Program, Princess Margaret Cancer Centre, Toronto, ON, M5G 2C1, Canada., Gilligan AM; Karyopharm Therapeutics, Newton, MA 02459, USA., Leong H; Karyopharm Therapeutics, Newton, MA 02459, USA., Ma X; Karyopharm Therapeutics, Newton, MA 02459, USA., Somaiah N; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Chawla SP; Sarcoma Oncology Center, Santa Monica, CA 90403, USA., Martin-Broto J; Institute of Biomedicine Research (IBIS)/CSIC/Universidad de Sevilla, Virgen del Rocio University Hospital, Calle Antonio Maura Montaner, 41013, Sevilla, Spain., Grignani G; Division of Medical Oncology, Candiolo Cancer Institute, FPO-IRCCS, 10060, Candiolo (TO), Italy., Schuetze SM; Division of Hematology/Oncology, University of Michigan, Ann Arbor, MI 48109, USA., Vincenzi B; Policlinico Universitario Campus, Bio-Medico, Via Álvaro del Portillo, 200, 00128, Roma, Italy., Wagner AJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Chmielowski B; Division of Hematology-Oncology, Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, CA 90024, USA., Jones RL; The Royal Marsden NHS Foundation Trust & The Institute of Cancer Research, London, SM2 5PT, UK., Shah J; Karyopharm Therapeutics, Newton, MA 02459, USA., Shacham S; Karyopharm Therapeutics, Newton, MA 02459, USA., Kauffman M; Karyopharm Therapeutics, Newton, MA 02459, USA., Riedel RF; Department of Medicine, Duke University Medical Center, Durham, NC 27710, USA., Attia S; Department of Internal Medicine, Division of Hematology/Oncology, Mayo Clinic, Jacksonville, FL 32224, USA.
Publikováno v:
Future oncology (London, England) [Future Oncol] 2021 Aug; Vol. 17 (22), pp. 2923-2939. Date of Electronic Publication: 2021 Apr 15.
Autor:
Vidal GA; West Cancer Center and Research Institute, Germantown, TN., Carter GC; Eli Lilly and Company, Indianapolis, IN., Gilligan AM; ConcertAI (formerly Vector Oncology), Memphis, TN. Electronic address: adrienne.texas@gmail.com., Saverno K; Eli Lilly and Company, Indianapolis, IN., Zhu YE; Eli Lilly and Company, Indianapolis, IN., Price GL; Eli Lilly and Company, Indianapolis, IN., DeLuca A; Eli Lilly and Company, Indianapolis, IN., Smyth EN; Eli Lilly and Company, Indianapolis, IN., Rybowski S; Eli Lilly and Company, Indianapolis, IN., Huang YJ; Eli Lilly and Company, Indianapolis, IN., Schwartzberg LS; West Cancer Center and Research Institute, Germantown, TN.
Publikováno v:
Clinical breast cancer [Clin Breast Cancer] 2021 Aug; Vol. 21 (4), pp. 317-328.e7. Date of Electronic Publication: 2021 Jan 01.